PCA
WST icon

Purkiss Capital Advisors’s West Pharmaceutical WST Stock Holding History

Purkiss Capital Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$815K Sell
2,269
-250
-10% -$76.4K 0.31% 75
2026
Q1 		$631K Hold
2,519
– – 0.28% 79
2025
Q4 		$693K Hold
2,519
– – 0.32% 66
2025
Q3 		$661K Hold
2,519
– – 0.32% 69
2025
Q2 		$551K Hold
2,519
– – 0.31% 70
2025
Q1 		$564K Hold
2,519
– – 0.43% 49
2024
Q4 		$825K Buy
+2,519
New +$793K 0.71% 28

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 20.5% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Purkiss Capital Advisors's WST Position: Q2 2026 in Review

Purkiss Capital Advisors reduced its West Pharmaceutical (WST) stake by 9.9% in Q2 2026, selling an estimated $76.4K and leaving 2,269 shares worth $815K. The position accounts for 0.31% of the portfolio, ranked #75.

Purkiss Capital Advisors first reported a position in WST in Q4 2024 and has held it in 7 quarters since. The position peaked at $825K in Q4 2024. 287 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Purkiss Capital Advisors held 2,269 shares of West Pharmaceutical worth $815K as of Q2 2026.
  • Purkiss Capital Advisors sold 250 West Pharmaceutical shares in Q2 2026, an estimated $76.4K.
  • West Pharmaceutical made up 0.31% of Purkiss Capital Advisors's portfolio in Q2 2026, its #75 holding.
  • Purkiss Capital Advisors first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • Purkiss Capital Advisors's West Pharmaceutical position peaked at $825K in Q4 2024.
  • 287 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Purkiss Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.